The Master in Immuno-oncology is an annual program focused on the rapidly advancing field of cancer treatment through immunotherapy. This program provides specialized knowledge and skills in understanding and applying immunological approaches to combat cancer.
The Master's program is structured over one academic year, encompassing 60 ECTS credits, reflecting a comprehensive study load.
Details regarding admission and specific requirements are typically found in the official announcement (Bando). Auditors may have different payment modalities, as noted on the program page.
The tuition fee is €2500. Information on payment modalities for auditors is available in the download section. For the academic year 2016/2017, there were updates regarding auditor payments.
The program is part of Sapienza University of Rome's offerings.
The tuition fee for the Master in Immuno-oncology is €2500 per year, applicable to both home and international students. Information on payment modalities for auditors is available in the download section.
The Master in Immuno-oncology is an annual program, structured over one academic year and encompassing 60 ECTS credits.
Admission requires a relevant first-cycle degree (Laurea Triennale or equivalent). Specific admission requirements, deadlines, and procedures are detailed in the official announcement (Bando).
To apply, you should review the Official Announcement (Bando), prepare required documents such as academic transcripts, CV, and a motivation letter, and submit your application through the designated portal by the deadline.
While specific scores are not mentioned, English language proficiency is generally expected. Sapienza's Language Centre (CLA) offers online tests and recognizes Cambridge certifications.
This program equips graduates for specialized roles in research, clinical practice, and the pharmaceutical industry within the field of cancer immunology.